The emerging approach of the medication represents a significant advance in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide impacts multiple pathways – the GLP-1 hormone and GIP – leading to https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment